Stockreport

ARCA Biopharma Announces Third Quarter 2019 Financial Results and Provides Corporate Update

ARCA biopharma, Inc.  (ABIO) 
US:NASDAQ Investor Relations: arcabio.com/investors
PDF PRECISION-AF pivotal Phase 3 clinical trial initiation anticipated first quarter of 2020Trial to examine atrial fibrillation in a heart failure population for which ther [Read more]